{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:45:29Z","timestamp":1795085129147,"version":"4.10.2"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19, the global threat to humanity, shares etiological cofactors with multiple diseases including Alzheimer\u2019s disease (AD). Understanding the common links between COVID-19 and AD would harness strategizing therapeutic approaches against both. Considering the urgency of formulating COVID-19 medication, its AD association and manifestations have been reviewed here, putting emphasis on memory and learning disruption. COVID-19 and AD share common links with respect to angiotensin-converting enzyme 2 (ACE2) receptors and pro-inflammatory markers such as interleukin-1 (IL-1), IL-6, cytoskeleton-associated protein 4 (CKAP4), galectin-9 (GAL-9 or Gal-9), and APOE4 allele. Common etiological factors and common manifestations described in this review would aid in developing therapeutic strategies for both COVID-19 and AD and thus impact on eradicating the ongoing global threat. Thus, people suffering from COVID-19 or who have come round of it as well as people at risk of developing AD or already suffering from AD, would be benefitted.<\/jats:p>","DOI":"10.1007\/s12035-020-02177-w","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T18:02:58Z","timestamp":1603130578000},"page":"1017-1023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Neurobiochemical Cross-talk Between COVID-19 and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3113-0313","authenticated-orcid":false,"given":"Mohammad Azizur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamrul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"1","key":"2177_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/v12010014","volume":"12","author":"M Desforges","year":"2019","unstructured":"Desforges M, Le Coupanec A, Dubeau P (2019) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 12(1):14. https:\/\/doi.org\/10.3390\/v12010014","journal-title":"Viruses"},{"key":"2177_CR2","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.jns.2020.116832","volume":"413","author":"AA Asadi-Pooya","year":"2020","unstructured":"Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832. https:\/\/doi.org\/10.1016\/j.jns.2020.116832","journal-title":"J Neurol Sci"},{"issue":"6","key":"2177_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):1\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"issue":"1","key":"2177_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","volume":"76","author":"M Fotuhi","year":"2020","unstructured":"Fotuhi M, Mian A, Meysami S, Raji CA (2020) Neurobiology of COVID-19. J Alzheimers Dis 76(1):3\u201319. https:\/\/doi.org\/10.3233\/JAD-200581","journal-title":"J Alzheimers Dis"},{"issue":"5054","key":"2177_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"7","key":"2177_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995\u2013998","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"2177_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jmv.25728","volume":"92","author":"YC Li","year":"2020","unstructured":"Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92(6):552\u2013555. https:\/\/doi.org\/10.1002\/jmv.25728","journal-title":"J Med Virol"},{"issue":"6483","key":"2177_CR8","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483):1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science"},{"issue":"7","key":"2177_CR9","doi-asserted-by":"publisher","first-page":"1549.e3","DOI":"10.1016\/j.ajem.2020.05.024","volume":"38","author":"R Bridwell","year":"2020","unstructured":"Bridwell R, Long B, Gottlieb M (2020) Neurologic complications of COVID-19. Am J Emerg Med 38(7):1549.e3\u20131549.e7. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.024","journal-title":"Am J Emerg Med"},{"issue":"5","key":"2177_CR10","doi-asserted-by":"publisher","first-page":"e8192","DOI":"10.7759\/cureus.8192","volume":"12","author":"M Sheraton","year":"2020","unstructured":"Sheraton M, Deo N, Kashyap R (2020) A review of neurological complications of COVID-19. Cureus 12(5):e8192. https:\/\/doi.org\/10.7759\/cureus.8192","journal-title":"Cureus"},{"issue":"3","key":"2177_CR11","doi-asserted-by":"publisher","first-page":"e13473","DOI":"10.1111\/apha.13473","volume":"229","author":"L Steardo","year":"2020","unstructured":"Steardo L, Steardo L Jr, Zorec R, Verkhratsky A (2020) Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxford) 229(3):e13473. https:\/\/doi.org\/10.1111\/apha.13473","journal-title":"Acta Physiol (Oxford)"},{"key":"2177_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.03","volume":"87","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xu X, Chen Z (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2020.03.03","journal-title":"Brain Behav Immun"},{"issue":"5","key":"2177_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1124\/molpharm.120.000014","volume":"97","author":"N Kabbani","year":"2020","unstructured":"Kabbani N, Olds JL (2020) Does COVID19 infect the brain? If so, smokers might be at a higher risk. Mol Pharmacol 97(5):351\u2013353. https:\/\/doi.org\/10.1124\/molpharm.120.000014","journal-title":"Mol Pharmacol"},{"issue":"1","key":"2177_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/ane.13266","volume":"142","author":"A Whittaker","year":"2020","unstructured":"Whittaker A, Anson M, Harky A (2020) Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand 142(1):14\u201322. https:\/\/doi.org\/10.1111\/ane.13266","journal-title":"Acta Neurol Scand"},{"key":"2177_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41582-020-0368-9","volume":"16","author":"H Hartung","year":"2020","unstructured":"Hartung H, Aktas O (2020) COVID-19 and management of neuroimmunological disorders. Nat Rev Neurol 16:347\u2013348. https:\/\/doi.org\/10.1038\/s41582-020-0368-9","journal-title":"Nat Rev Neurol"},{"issue":"20","key":"2177_CR16","doi-asserted-by":"publisher","first-page":"30287","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"S2215-0366","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj A, Thomas N, Ellul MA (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry S2215-0366(20):30287\u20133028X. https:\/\/doi.org\/10.1016\/S2215-0366(20)30287-X","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"2177_CR17","doi-asserted-by":"publisher","first-page":"e7889","DOI":"10.7759\/cureus.7889","volume":"12","author":"D Lahiri","year":"2020","unstructured":"Lahiri D, Ardila A (2020) COVID-19 pandemic: a neurological perspective. Cureus 12(4):e7889. https:\/\/doi.org\/10.7759\/cureus.7889","journal-title":"Cureus"},{"issue":"1","key":"2177_CR18","first-page":"55","volume":"49","author":"IM Cojocaru","year":"2011","unstructured":"Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer\u2019s disease. Rom J Intern Med 49(1):55\u201358","journal-title":"Rom J Intern Med"},{"issue":"1","key":"2177_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.imlet.2007.09.002","volume":"114","author":"M Motta","year":"2007","unstructured":"Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L (2007) Altered plasma cytokine levels in Alzheimer\u2019s disease: correlation with the disease progression. Immunol Lett 114(1):46\u201351. https:\/\/doi.org\/10.1016\/j.imlet.2007.09.002","journal-title":"Immunol Lett"},{"key":"2177_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nlm.2018.06.006","volume":"155","author":"I Bialuk","year":"2018","unstructured":"Bialuk I, Taranta A, Winnicka MM (2018) IL-6 deficiency alters spatial memory in 4- and 24-month-old mice. Neurobiol Learn Mem 155:21\u201329. https:\/\/doi.org\/10.1016\/j.nlm.2018.06.006","journal-title":"Neurobiol Learn Mem"},{"key":"2177_CR21","doi-asserted-by":"publisher","unstructured":"Chen X, Zhao B, Qu Y, Chen Y (2020) Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis ciaa449. https:\/\/doi.org\/10.1093\/cid\/ciaa449","DOI":"10.1093\/cid\/ciaa449"},{"key":"2177_CR22","doi-asserted-by":"publisher","unstructured":"Wang H, Luo S, Shen Y, Li M (2020) Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: a multi-centered, correlation study with CT imaging score. https:\/\/ssrn.com\/abstract=3544837 or https:\/\/doi.org\/10.2139\/ssrn.3544837. Accessed 2 March 2020","DOI":"10.2139\/ssrn.3544837"},{"issue":"4","key":"2177_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","volume":"50","author":"ZS Ulhaq","year":"2020","unstructured":"Ulhaq ZS, Soraya GV (2020) Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect 50(4):382\u2013383. https:\/\/doi.org\/10.1016\/j.medmal.2020.04.002","journal-title":"Med Mal Infect"},{"key":"2177_CR24","doi-asserted-by":"publisher","unstructured":"Patel H, Ashton NJ, Dobson RJ, Anderson LM (2020) Proteomic blood profiling in mild, severe and critical COVID-19 patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.06.22.20137216","DOI":"10.1101\/2020.06.22.20137216"},{"issue":"5","key":"2177_CR25","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q (2020) The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 55(5):105954. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2177_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0197-4580(96)00107-8","volume":"17","author":"M H\u00fcll","year":"1996","unstructured":"H\u00fcll M, Fiebich BL, Lieb K, Strauss S (1996) Interleukin-6-associated inflammatory processes in Alzheimer\u2019s disease: new therapeutic options. Neurobiol Aging 17(5):795\u2013800. https:\/\/doi.org\/10.1016\/0197-4580(96)00107-8","journal-title":"Neurobiol Aging"},{"issue":"32","key":"2177_CR27","doi-asserted-by":"publisher","first-page":"18951","DOI":"10.1073\/pnas.2009017117","volume":"117","author":"C Rapha\u00ebl","year":"2020","unstructured":"Rapha\u00ebl C, Marie K, David D, C\u00e9cile M (2020) Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. PNAS 117(32):18951\u201318953. https:\/\/doi.org\/10.1073\/pnas.2009017117","journal-title":"PNAS"},{"key":"2177_CR28","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C (2020) Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2:e325\u2013e331. https:\/\/doi.org\/10.1016\/S2665-9913(20)30127-2","journal-title":"Lancet Rheumatol"},{"issue":"19","key":"2177_CR29","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. PNAS 86(19):7611\u20137615","journal-title":"PNAS"},{"issue":"1","key":"2177_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0149-7634(00)00048-8","volume":"25","author":"RC Pugh","year":"2001","unstructured":"Pugh RC, Fleshner M, Watkins LR, Maier SF, Rudy JW (2001) The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev 25(1):29\u201341","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"2177_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","volume":"17","author":"JG Sheng","year":"1996","unstructured":"Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WS (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 17(5):761\u2013766","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2177_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hipo.10164","volume":"14","author":"AM Depino","year":"2004","unstructured":"Depino AM, Alonso M, Ferrari C, del Rey A, Anthony D (2004) Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus 14(4):526\u2013535","journal-title":"Hippocampus"},{"key":"2177_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virusres.2014.10.011","volume":"195","author":"X Lu","year":"2015","unstructured":"Lu X, McCoy KS, Xu J, Hu W (2015) Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells. Virus Res 195:162\u2013171. https:\/\/doi.org\/10.1016\/j.virusres.2014.10.011","journal-title":"Virus Res"},{"key":"2177_CR34","doi-asserted-by":"publisher","first-page":"e9392","DOI":"10.7717\/peerj.9392","volume":"8","author":"JL Caniglia","year":"2020","unstructured":"Caniglia JL, Guda MR, Asuthkar S (2020) A potential role for galectin-3 inhibitors in the treatment of COVID-19. Peer J 8:e9392. https:\/\/doi.org\/10.7717\/peerj.9392","journal-title":"Peer J"},{"key":"2177_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2016.09.003","volume":"96","author":"M Rinaldi","year":"2016","unstructured":"Rinaldi M, Thomas L, Mathieu P, Carabias P (2016) Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization\/phagocytosis and oligodendroglial differentiation. Neurobiol Dis 96:127\u2013143","journal-title":"Neurobiol Dis"},{"issue":"8","key":"2177_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/1533317513495107","volume":"30","author":"X Wang","year":"2015","unstructured":"Wang X, Zhang S, Lin F, Chu W, Yue S (2015) Elevated galectin-3 levels in the serum of patients with Alzheimer\u2019s disease. Am J Alzheimers Dis Other 30(8):729\u2013732. https:\/\/doi.org\/10.1177\/1533317513495107","journal-title":"Am J Alzheimers Dis Other"},{"issue":"1","key":"2177_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","volume":"27","author":"CC Tao","year":"2020","unstructured":"Tao CC, Cheng KM, Ma YL, Hsu WL (2020) Galectin-3 promotes A\u03b2 oligomerization and A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease. Cell Death Differ 27(1):192\u2013209. https:\/\/doi.org\/10.1038\/s41418-019-0348-z","journal-title":"Cell Death Differ"},{"issue":"31","key":"2177_CR38","doi-asserted-by":"publisher","first-page":"12569","DOI":"10.1523\/JNEUROSCI.1251-13.2013","volume":"33","author":"GI Cancino","year":"2013","unstructured":"Cancino GI, Yiu AP, Fatt MP, Dugani CB (2013) p63 regulates adult neural precursor and newly born neuron survival to control hippocampal-dependent behavior. J Neurosci 33(31):12569\u201312585. https:\/\/doi.org\/10.1523\/JNEUROSCI.1251-13.2013","journal-title":"J Neurosci"},{"issue":"6","key":"2177_CR39","doi-asserted-by":"publisher","first-page":"L794","DOI":"10.1152\/ajplung.00372.2009","volume":"299","author":"AS Kazi","year":"2010","unstructured":"Kazi AS, Tao JQ, Feinstein SI, Zhang L, Fisher AB, Bates SR (2010) Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 299(6):L794\u2013L807. https:\/\/doi.org\/10.1152\/ajplung.00372.2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"2177_CR40","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.ajpath.2018.03.007","volume":"188","author":"K Yanagita","year":"2018","unstructured":"Yanagita K, Nagashio R, Jiang SX, Kuchitsu Y (2018) Cytoskeleton-associated protein 4 is a novel serodiagnostic marker for lung cancer. Am J Pathol 188(6):1328\u20131333. https:\/\/doi.org\/10.1016\/j.ajpath.2018.03.007","journal-title":"Am J Pathol"},{"issue":"8","key":"2177_CR41","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","volume":"33","author":"K Hultman","year":"2013","unstructured":"Hultman K, Strickland S, Norris EH (2013) The APOE \u025b4\/\u025b4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer\u2019s disease patients. J Cereb Blood Flow Metab 33(8):1251\u20131258","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"2177_CR42","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1212\/01.wnl.0000210447.19748.0b","volume":"66","author":"MS Beeri","year":"2006","unstructured":"Beeri MS, Rapp M, Silverman JM, Schmeidler J (2006) Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 66(9):1399\u20131404. https:\/\/doi.org\/10.1212\/01.wnl.0000210447.19748.0b","journal-title":"Neurology"},{"key":"2177_CR43","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","volume":"glaa131","author":"CL Kuo","year":"2020","unstructured":"Kuo CL, Pilling LC, Atkins JL, Masoli J (2020) APOEe4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci glaa131:2231\u20132232. https:\/\/doi.org\/10.1093\/gerona\/glaa131","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"2177_CR44","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","volume":"81","author":"KH Lim","year":"2020","unstructured":"Lim KH, Yang S, Kim SH, Joo JY (2020) Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease. J Inf Secur 81(3):e33\u2013e34. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.072","journal-title":"J Inf Secur"},{"key":"2177_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1073858403261226","volume":"10","author":"AJ Susswein","year":"2004","unstructured":"Susswein AJ, Katzoff A, Miller N, Hurwitz I (2004) Nitric oxide and memory. Neuroscientist 10:153\u2013162","journal-title":"Neuroscientist"},{"key":"2177_CR46","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/jgs.16536","volume":"10","author":"WA Alkeridy","year":"2020","unstructured":"Alkeridy WA, Almaghlouth I, Alrashed R (2020) A unique presentation of delirium in a patient with otherwise asymptomatic COVID-19. J Am Geriatr Soc 10:1111\u20131384. https:\/\/doi.org\/10.1111\/jgs.16536","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2177_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/biom10010040","volume":"10","author":"GD Stanciu","year":"2019","unstructured":"Stanciu GD, Luca A, Rusu RN (2019) Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement. Biomolecules 10(1):40. Published 2019 Dec 26. https:\/\/doi.org\/10.3390\/biom10010040","journal-title":"Biomolecules"},{"issue":"13","key":"2177_CR48","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2174\/1389450117666161005145143","volume":"18","author":"SM Farhat","year":"2017","unstructured":"Farhat SM, Ahmed T (2017) Neuroprotective and neurotoxic implications of \u03b17 nicotinic acetylcholine receptor and A\u03b2 interaction: therapeutic options in Alzheimer\u2019s disease. Curr Drug Targets 18(13):1537\u20131544. https:\/\/doi.org\/10.2174\/1389450117666161005145143","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2177_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/mmr.2019.10374","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K (2019) Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (review). Mol Med Rep 20(2):1479\u20131487. https:\/\/doi.org\/10.3892\/mmr.2019.10374","journal-title":"Mol Med Rep"},{"issue":"1","key":"2177_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14283\/jpad.2018.43","volume":"6","author":"H Hampel","year":"2019","unstructured":"Hampel H, Mesulam MM, Cuello AC (2019) Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research. J Prev Alzheimers Dis 6(1):2\u201315. https:\/\/doi.org\/10.14283\/jpad.2018.43","journal-title":"J Prev Alzheimers Dis"},{"key":"2177_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.05.002","volume":"179","author":"DB Hoover","year":"2017","unstructured":"Hoover DB (2017) Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Ther 179:1\u201316. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.002","journal-title":"Pharmacol Ther"},{"key":"2177_CR52","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ejphar.2015.07.038","volume":"764","author":"MA Gowayed","year":"2015","unstructured":"Gowayed MA, Refaat R, Ahmed WM, El-Abhar HS (2015) Effect of galantamine on adjuvant-induced arthritis in rats. Eur J Pharmacol 764:547\u2013553","journal-title":"Eur J Pharmacol"},{"key":"2177_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1797","volume":"4","author":"L Ulloa","year":"2005","unstructured":"Ulloa L (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4:673\u2013684","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2177_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5802\/crbiol.8","volume":"343","author":"JP Changeux","year":"2020","unstructured":"Changeux JP, Amoura Z, Rey FA, Miyara M (2020) A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. C R Biol 343(1):33\u201339. Published 2020 Jun 5. https:\/\/doi.org\/10.5802\/crbiol.8","journal-title":"C R Biol"},{"key":"2177_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.toxrep.2020.04.012","volume":"7","author":"K Farsalinos","year":"2020","unstructured":"Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K (2020) Editorial: nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 7:658\u2013663","journal-title":"Toxicol Rep"},{"issue":"1","key":"2177_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159x13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101\u2013115. https:\/\/doi.org\/10.2174\/1570159x13666150716165726","journal-title":"Curr Neuropharmacol"},{"key":"2177_CR57","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7058341","volume":"215","author":"PJ Whitehouse","year":"1982","unstructured":"Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1237\u20131239. https:\/\/doi.org\/10.1126\/science.7058341","journal-title":"Science."},{"key":"2177_CR58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/NEN.0b013e318288a8dd","volume":"72","author":"JJ Ramos-Rodriguez","year":"2013","unstructured":"Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL (2013) Rapid b-amyloid deposition and cognitive impairment after cholinergic denervation in APP\/PS1 mice. J Neuropathol Exp Neurol 72:272\u2013285","journal-title":"J Neuropathol Exp Neurol"},{"key":"2177_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/00001756-199503000-00012","volume":"6","author":"F Mori","year":"1995","unstructured":"Mori F, Lai CC, Fusi F, Giacobini E (1995) Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuroreport 6:633\u2013636","journal-title":"Neuroreport"},{"issue":"7","key":"2177_CR60","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 141(7):1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132","journal-title":"Brain."},{"issue":"1","key":"2177_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/JAD-200537","volume":"76","author":"SX Naughton","year":"2020","unstructured":"Naughton SX, Raval U, Pasinetti GM (2020) Potential novel role of COVID-19 in Alzheimer\u2019s disease and preventative mitigation strategies. J Alzheimers Dis 76(1):21\u201325. https:\/\/doi.org\/10.3233\/JAD-200537","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"2177_CR62","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/alr.22587","volume":"10","author":"ST Moein","year":"2020","unstructured":"Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL (2020) Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol 10(8):944\u2013950. https:\/\/doi.org\/10.1002\/alr.22587","journal-title":"Int Forum Allergy Rhinol"},{"key":"2177_CR63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0140-6736(99)90402-6","volume":"355","author":"A Burns","year":"2000","unstructured":"Burns A (2000) Might olfactory dysfunction be a marker of early Alzheimer\u2019s disease? Lancet. 355:84\u201385","journal-title":"Lancet."},{"issue":"6","key":"2177_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/chemse\/bjaa040","volume":"45","author":"AY Han","year":"2020","unstructured":"Han AY, Mukdad L, Long JL, Lopez IA (2020) Anosmia in COVID-19: mechanisms and significance. Chem Senses 45(6):423\u2013428. https:\/\/doi.org\/10.1093\/chemse\/bjaa040","journal-title":"Chem Senses"},{"key":"2177_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/JTS.1000397","volume":"7","author":"O Equils","year":"2020","unstructured":"Equils O, Lekaj K, Fattani S, Wu A, Liu G (2020) Proposed mechanism for anosmia during COVID-19: the role of local zinc distribution. J Translan Sci 7:1\u20132. https:\/\/doi.org\/10.15761\/JTS.1000397","journal-title":"J Translan Sci"},{"issue":"7","key":"2177_CR66","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/1533317510382283","volume":"25","author":"GJ Brewer","year":"2010","unstructured":"Brewer GJ, Kanzer SH, Zimmerman EA, Molho ES, Celmins DF, Heckman SM, Dick R (2010) Subclinical zinc deficiency in Alzheimer\u2019s disease and Parkinson's disease. Am J Alzheimers Dis Other Dement 25(7):572\u2013575. https:\/\/doi.org\/10.1177\/1533317510382283","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"2177_CR67","doi-asserted-by":"publisher","unstructured":"Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M (2020) COVID-19 and comorbidities: a systematic review and meta-analysis [published online ahead of print, 2020 Jul 14]. Postgrad Med:1\u20137. https:\/\/doi.org\/10.1080\/00325481.2020.1786964","DOI":"10.1080\/00325481.2020.1786964"},{"issue":"7","key":"2177_CR68","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/ggi.13960","volume":"20","author":"M Covino","year":"2020","unstructured":"Covino M, De Matteis G, Santoro M et al (2020) Clinical characteristics and prognostic factors in COVID-19 patients aged \u226580\u2009years. Geriatr Gerontol Int 20(7):704\u2013708. https:\/\/doi.org\/10.1111\/ggi.13960","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"2177_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12802","volume":"17","author":"X Xia","year":"2018","unstructured":"Xia X, Jiang Q, McDermott J, Han JJ (2018) Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level. Aging Cell 17(5):e12802. https:\/\/doi.org\/10.1111\/acel.12802","journal-title":"Aging Cell"},{"issue":"4","key":"2177_CR70","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S1049023X20000837","volume":"35","author":"P Maleki Dana","year":"2020","unstructured":"Maleki Dana P, Sadoughi F, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B, Momen-Heravi M (2020) An insight into the sex differences in COVID-19 patients: what are the possible causes? Prehosp Disaster Med 35(4):438\u2013441. https:\/\/doi.org\/10.1017\/S1049023X20000837","journal-title":"Prehosp Disaster Med"},{"key":"2177_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2020.05.026","volume":"315","author":"IY Elgendy","year":"2020","unstructured":"Elgendy IY, Pepine CJ (2020) Why are women better protected from COVID-19: clues for men? Sex and COVID-19. Int J Cardiol 315:105\u2013106. https:\/\/doi.org\/10.1016\/j.ijcard.2020.05.026","journal-title":"Int J Cardiol"},{"issue":"1\u20132","key":"2177_CR72","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ (2017) Sex and the development of Alzheimer\u2019s disease. J Neurosci Res 95(1\u20132):671\u2013680. https:\/\/doi.org\/10.1002\/jnr.23827","journal-title":"J Neurosci Res"},{"issue":"9","key":"2177_CR73","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jalz.2018.08.003","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS (2018) Sex and gender in Alzheimer\u2019s disease - does it matter? Alzheimers Dement 14(9):1101\u20131103. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.003","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2177_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370. https:\/\/doi.org\/10.1111\/ene.13439","journal-title":"Eur J Neurol"},{"issue":"6","key":"2177_CR75","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1208\/s12249-020-01756-3","volume":"21","author":"H Jamshaid","year":"2020","unstructured":"Jamshaid H, Zahid F, Din IU et al (2020) Diagnostic and treatment strategies for COVID-19. AAPS PharmSciTech 21(6):222. Published 2020 Aug 3. https:\/\/doi.org\/10.1208\/s12249-020-01756-3","journal-title":"AAPS PharmSciTech"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02177-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:32:40Z","timestamp":1634625160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02177-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02177-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}